Zobrazit více v PubMed

J Immunol. 1948 Jun;59(2):129-34 PubMed

J Exp Med. 1963 Sep 1;118:425-46 PubMed

J Exp Med. 1947 Jun 30;86(1):29-38 PubMed

Proc Soc Exp Biol Med. 1953 Apr;82(4):754-61 PubMed

J Exp Med. 1963 Jan 1;117:139-47 PubMed

J Infect Dis. 1955 Jan-Feb;96(1):14-8 PubMed

Ann N Y Acad Sci. 1960 Jun 21;88:99-106 PubMed

Yale J Biol Med. 1963 Jun;35:489-503 PubMed

Proc Soc Exp Biol Med. 1946 Mar;61:248-50 PubMed

Bacteriol Rev. 1947 Dec;11(4):275-302 PubMed

J Exp Med. 1947 Jun 30;86(1):39-44 PubMed

J Exp Med. 1961 Sep 1;114:363-74 PubMed

J Clin Invest. 1958 Mar;37(3):441-57 PubMed

Medicine (Baltimore). 1950 Dec;29(4):365-400 PubMed

J Exp Med. 1960 Jan 1;111:137-44 PubMed

J Exp Med. 1960 Apr 1;111:453-63 PubMed

J Exp Med. 1961 Dec 1;114:939-59 PubMed

J Exp Med. 1964 Feb 1;119:241-64 PubMed

Physiol Rev. 1960 Jul;40:580-646 PubMed

J Exp Med. 1963 Apr 1;117:663-74 PubMed

J Exp Med. 1960 Feb 1;111:255-84 PubMed

Yale J Biol Med. 1963 Jun;35:472-88 PubMed

J Exp Med. 1958 Mar 1;107(3):415-35 PubMed

Effect of scarlet fever toxin on the phagocytic activity of the reticuloendothelial system

The production of migration inhibitory factor (MIF) in rabbit lymphocytes by other than immunological mechanism

The pathophysiological effect of scarlet fever toxin. I. Its effect on the white blood picture

The pyrogenic effect of scarlet fever toxin. 3. The effect of cortisone on the pyrogenic, lethal and dermal activity of scarlet fever toxin

The pyrogenic effect of scarlet fever toxin. II. Leukocytic pyrogen formation induced by scarlet fever toxin or Salmonella paratyphi B endotoxin